Poisoning by thrombolytic drug, intentional self-harm, init

This code signifies a patient presenting with adverse effects resulting from the deliberate ingestion or administration of a thrombolytic medication with the intent to cause self-harm. Thrombolytic drugs are potent medications designed to dissolve blood clots, and their misuse can lead to severe and life-threatening bleeding complications. The "initial encounter" designation indicates that the patient is receiving active treatment for the poisoning.

Apply this code when documentation clearly states a patient intentionally overdosed on a thrombolytic agent, such as alteplase, reteplase, or tenecteplase, and is currently undergoing initial evaluation and management for the poisoning. This would include emergency department visits, initial hospital admissions, or transfers for acute care related to the self-harm event.

• Always verify the intent of self-harm is explicitly documented by the provider.
• Ensure the specific substance is identified as a thrombolytic drug, not just a general anticoagulant.
• Pair this code with any relevant external cause codes (e.g., X61.0XXA for intentional self-harm by antithrombotic drugs) and codes for specific manifestations of the poisoning (e.g., hemorrhage).